語系/ Language:
繁體中文
English
KMU OLIS
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Uremic toxins and organ failure
~
Saito, Hideyuki.
Uremic toxins and organ failure
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Uremic toxins and organ failure/ edited by Hideyuki Saito, Takaaki Abe.
其他作者:
Abe, Takaaki.
出版者:
Singapore :Springer Singapore : : 2020.,
面頁冊數:
viii, 180 p. :ill. (some col.), digital ; : 24 cm.;
提要註:
This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.
Contained By:
Springer Nature eBook
標題:
Cardiology. -
電子資源:
https://doi.org/10.1007/978-981-15-7793-2
ISBN:
9789811577932
Uremic toxins and organ failure
Uremic toxins and organ failure
[electronic resource] /edited by Hideyuki Saito, Takaaki Abe. - Singapore :Springer Singapore :2020. - viii, 180 p. :ill. (some col.), digital ;24 cm.
1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.
This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.
ISBN: 9789811577932
Standard No.: 10.1007/978-981-15-7793-2doiSubjects--Topical Terms:
217407
Cardiology.
LC Class. No.: RC915
Dewey Class. No.: 616.635
Uremic toxins and organ failure
LDR
:02605nam a2200325 a 4500
001
338641
003
DE-He213
005
20201012134810.0
006
m d
007
cr nn 008maaau
008
210622s2020 si s 0 eng d
020
$a
9789811577932
$q
(electronic bk.)
020
$a
9789811577925
$q
(paper)
024
7
$a
10.1007/978-981-15-7793-2
$2
doi
035
$a
978-981-15-7793-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC915
072
7
$a
MJR
$2
bicssc
072
7
$a
MED055000
$2
bisacsh
072
7
$a
MJR
$2
thema
082
0 4
$a
616.635
$2
23
090
$a
RC915
$b
.U75 2020
245
0 0
$a
Uremic toxins and organ failure
$h
[electronic resource] /
$c
edited by Hideyuki Saito, Takaaki Abe.
260
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2020.
300
$a
viii, 180 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
505
0
$a
1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.
520
$a
This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.
650
2 4
$2
96060
$a
Cardiology.
$3
217407
650
2 4
$2
96060
$a
Gastroenterology.
$3
255658
650
1 4
$2
96060
$a
Nephrology.
$3
218718
650
0
$a
Multiple organ failure.
$3
467012
650
0
$a
Uremia.
$3
467011
700
1
$a
Abe, Takaaki.
$3
467010
700
1
$a
Saito, Hideyuki.
$3
467009
710
2
$2
97100
$a
SpringerLink (Online service)
$3
255133
773
0
$t
Springer Nature eBook
856
4 0
$u
https://doi.org/10.1007/978-981-15-7793-2
950
$a
Medicine (SpringerNature-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得,請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論,館方有權利刪除任何違反評論規則之發言,情節嚴重者一律停權,以維護所有讀者的自由言論空間。
Export
取書館別
處理中
...
變更密碼
登入